Skip to Content
Morningstar

Haleon PLC ADR HLN

Morningstar Rating
Unlock
Stock XNYS Rating as of
$8.40 +0.05 (0.60%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Haleon: CFO Transition Due to Health Concerns; No Impact on Valuation or Moat

Keonhee Kim

Wide-moat Haleon reported on April 24 that its chief financial officer, Tobias Hestler, will be stepping down due to long-term health conditions and will be replaced by Dawn Allen. Allen is currently serving as the CFO of Tate & Lyle, a food and beverage products supplier, and has previously worked at Mars for over 20 years tackling various roles, including vice president and global CFO, global transformation at Mars Inc. Allen will join Haleon on Oct. 28, 2024, and we think she brings in decades of knowledge and relevant experience in the consumer industry to help the management team steer the company in the right direction.

Read Full Report

Price vs Fair Value

View History
HLN is trading at a 3% discount.
Price
$8.41
Fair Value
$6.80
Uncertainty
Medium
1-Star Price
$54.39
5-Star Price
$6.31
Economic Moat
Xbff
Capital Allocation
Fwfgnlp

Bulls Say, Bears Say

Bulls

We expect Haleon, with financial and operational independence, to bolster its portfolio through product innovation and tuck-in acquisitions and expand the strong foothold it has in the consumer self-care industry.

Bears

Personalization of health paves way for smaller niche players to carve out their shares of the market with bespoke offerings and Haleon will have a tough time fighting for these areas given the difficulty to cater to these consumers with their megabrands.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HLN is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$8.35
Day Range
$8.31–8.42
52-Week Range
$7.70–8.99
Bid/Ask
$8.30 / $8.50
Market Cap
$38.36 Bil
Volume/Avg
2.3 Mil / 5.9 Mil

Key Statistics

Price/Earnings (Normalized)
18.28
Price/Sales
2.77
Dividend Yield (Trailing)
1.82%
Dividend Yield (Forward)
2.55%
Total Yield
1.81%

Company Profile

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Large Core
Total Number of Employees
25,408
Website
https://www.haleon.com

Competitors

Valuation

View More
Metric
HLN
RKT
PG
Price/Earnings (Normalized)
 18.289.6124.89
Price/Book Value
 1.833.687.79
Price/Sales
 2.772.144.78
Price/Cash Flow
 17.3611.5719.83
Price/Earnings
HLN
RKT
PG

Financial Strength

Metric
HLN
RKT
PG
Quick Ratio
 0.630.400.40
Current Ratio
 1.040.640.64
Interest Coverage
 4.879.0020.66
Quick Ratio
HLN
RKT
PG

Profitability

Metric
HLN
RKT
PG
Return on Assets (Normalized)
 4.68%8.60%13.82%
Return on Equity (Normalized)
 9.76%26.61%35.61%
Return on Invested Capital (Normalized)
 7.06%14.24%20.62%
Return on Assets
HLN
RKT
PG
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRDtftnnfldGqqxc$69.8 Bil
ZTS
Zoetis Inc Class AXykfkldyfHnzr$68.9 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRByzvmjdgFvhq$14.8 Bil
VTRS
Viatris IncSftzmpdWswv$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRMmdhklljRsdt$11.9 Bil
CTLT
Catalent IncBtfmnfrXmprjv$10.1 Bil
PRGO
Perrigo Co PLCBmhtgyqtLwgy$4.2 Bil
CURLF
Curaleaf Holdings IncFcqsmdncMdj$3.6 Bil
PBH
Prestige Consumer Healthcare IncSqzzjrqHpjylq$3.5 Bil

Sponsor Center